Implantable medical devices help improve the health of millions of people. Usually placed in patients' bodies through surgery, these devices treat a wide range of medical conditions, including cardiac and nervous system disorders.
The Food and Drug Administration (FDA) regulates all medical devices through its Center for Devices and Radiological Health (CDRH).
After the Food and Drug Administration (FDA) approves a product and it is on the market, FDA continues to monitor unexpected and undesirable side effects (adverse events) of that product.
Health care professionals and consumers may report side effects, product quality problems, product use errors, or therapeutic failure with the use of medical products to FDA's MedWatch Adverse Event Reporting program either online, by regular mail, by fax, or by phone.
Online at https://www.accessdata.fda...
Many of the implantable devices FDA regulates have been approved for pediatric use, meaning they can be used by people who are under the age of 21. Some of these devices are designed specifically for children and adolescents, while others are adapted from adult uses.
Devices for these younger groups present unique challenges, particularly for scientists who design the devices, health care professionals who recommend them, and parents and guardians who directly oversee their use.
Factors to Consider
Several factors may be considered in regard to implantable devices for children and adolescents. These include how active the child is, where the child is developmentally, the child's immunization history, and the impact the device will have on behavioral and social growth. Other factors to consider are
Physical growth: Children and their organs will likely undergo many periods of growth.
The child's development and the condition being treated: This may call for examination of how a device may affect the patient's brain development when devices are implanted in or near the brain. It also may call for examination of potential alternate implantation sites. For example, procedures involving the chest may affect the growth of breast buds in adolescent girls.
Surgical risks specific to children: Timing of surgery in relation to patient growth, disease progression, and medical history (such as immune system competency and susceptibility to infections) needs to be addressed.
The child's ability to manage the device safely: A child's age, maturity, strength, dexterity, and motor and sensory skills should be considered.
Safety Always a Top Priority
Proper device design and labeling are important, as well as appropriate training for patients and parents. These factors can reduce risks associated with, and ensure effective use of, implantable devices in children and adolescents.
Recently added provisions to FDA regulatory guidelines promote the development of safe and effective devices for children, and protect children during clinical studies.
recruits pediatric experts for its advisory panels when it seems likely that a device under discussion will be used for children
helps develop effective surveillance of pediatric medical devices once the devices are approved for marketing
collects data on the unmet needs of children, and identifies barriers to development of new products